The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data.
about
How should cost data in pragmatic randomised trials be analysed?Analysis of cost data in randomized trials: an application of the non-parametric bootstrap.Protocol for north of England and Scotland study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC). A pragmatic randomised controlled trial comparing surgical intervention with conventional medical treatment in children with recurrent sDevelopment of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgeryAn economic evaluation of rt-PA locking solution in dialysis catheters.Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.Predictors of costs in dementia in a longitudinal perspective.Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.Testing the generalizability of national reimbursement rates with respect to local setting: the costs of abdominal aortic aneurysm surgery in DenmarkMethadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates.Preoperative immunonutrition: cost-benefit analysis.Economic evaluations: a new avenue of outcome assessment in spinal disordersSocietal burden of clinically anxious youth referred for treatment: a cost-of-illness study.A randomised trial comparing the cost effectiveness of different emergency department healthcare professionals in soft tissue injury managementCost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemiaEconomic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial.Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment modelClinical and Economic Burden of Visual Impairment in an Aging Society of South Korea.A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention.Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.Hospice use and public expenditures at the end of life in assisted living residents in a Florida Medicaid waiver program.Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study.Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial.Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.Extrinsic goals and time tradeoff.Net costs of dementia by disease stage.Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.Magnetic resonance imaging for investigation of the knee joint: a clinical and economic evaluation.Does supplementary prenatal nursing and home visitation reduce healthcare costs in the year after childbirth?Leitlinienumsetzung und Kosten bei neudiagnostizierter Epilepsie
P2860
Q30593090-F269D3F9-557F-4B6E-B5EE-7E16009B4D30Q30620791-892823C5-F892-49D9-88C5-88F661578080Q30821242-1BB80F58-85CE-4A8F-A811-49DFBF162E7EQ33282214-E81064F5-A453-4C2A-A206-AD9B626A97D1Q34362686-81C0C029-8041-48B9-8188-233A4F5C6D1AQ34568730-92B318FD-2C1C-43EC-8F76-C0A659FC6357Q34669535-506C5633-B48E-47DF-9A33-ED62FD33F52CQ34854838-735B1783-FD26-44C0-84D2-D46812462F14Q34974133-FBC2E167-C343-41AC-AEC2-6E311728ED7BQ35205381-0B9E7A81-B186-4F10-9593-C02A82253C57Q35908532-B43C28DB-2CA1-4A95-A961-672E9EA2C0A8Q35975191-66C35DA6-A5F1-41C6-AF10-BD6E45D14792Q36040414-14040B50-AFCC-4123-AA9C-4E0D6B693255Q36266814-130D61EE-13D4-4309-9318-9434EA364FEEQ36514452-4768B435-E3B3-4475-85C2-ED1820449B40Q36546081-ACB6D587-95FD-42BE-9A78-236F8EC33C9AQ36735585-CFF91146-37ED-4B91-A0F8-E5857A6FBE03Q36768997-9C79F95E-B1EA-41B5-A582-06C6A3C75D5BQ36809974-5BE588F9-7A65-4978-B529-D80B3C21B032Q36961119-B8816BED-B3AA-4B62-B232-00D0F8C00EFCQ38515228-07BB6E1A-B88D-46D6-815D-517E34424CA4Q38779921-1E37FE92-29EF-4D5A-ADB7-0D94F77E80E8Q39262810-34CA1592-7908-4DA8-B760-6615A5ED2C26Q39278813-D9D56AE0-9FBC-435E-B672-1B83082EE691Q39334685-A7CF22F1-A144-42A5-A1C8-9A9DDAC4EF1EQ40239780-0C323461-AED4-40EC-97BB-FCDD8AAFCC6FQ40455116-3194EA18-9C9F-43F2-B338-F4DD845A9F38Q40667644-7A8C380E-A3A2-47E2-A501-23C1C91FD083Q41535274-F0F85F05-818C-4251-8B48-BAAA2D24DF5FQ41632919-B9EF60AA-0AD7-4183-A604-95607AF62964Q42674713-67729921-3851-4A00-BB2F-C1CB1D1AA4B2Q43358640-B206EDD2-9224-4445-9733-7491D59FB4CCQ46056923-DCD6508E-7F01-42FB-B916-799A8F1F79A9Q48240891-1647E8F3-55DB-4D30-9904-B5071A735242Q48395938-B1EB5C01-1CA7-4760-9BC2-25FFFA888397Q51168441-CD62E211-90B9-4369-A62C-CCA9AD95DA69Q53212639-2E756738-849C-43D5-B316-31A1ED6BD5F7Q53338388-45A5E9BA-C95C-4902-B7B8-6873E9D996B6Q58388689-F915564A-9141-41B8-BAB2-FD43FD369F15Q58594866-3A9C8A5A-75A9-475F-A9E9-0153F16682E9
P2860
The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
The use of the bootstrap stati ...... cost analysis of skewed data.
@ast
The use of the bootstrap stati ...... cost analysis of skewed data.
@en
type
label
The use of the bootstrap stati ...... cost analysis of skewed data.
@ast
The use of the bootstrap stati ...... cost analysis of skewed data.
@en
prefLabel
The use of the bootstrap stati ...... cost analysis of skewed data.
@ast
The use of the bootstrap stati ...... cost analysis of skewed data.
@en
P2093
P2860
P1433
P1476
The use of the bootstrap stati ...... cost analysis of skewed data.
@en
P2093
Castilloux AM
Desgagné A
LeLorier J
P2860
P304
P356
10.2165/00019053-199813050-00002
P433
P577
1998-05-01T00:00:00Z
P6179
1023485626